Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Jens Sydor"'
Autor:
Luca Ferrari, Wenkui Li, Christopher P. Evans, Lieve Dillen, Noah Post, Jens Sydor, Jinhui Zhang, Susan Stojdl, Boris Gorovits, Jason Boer, Anita Lee, Mark G. Qian, Natasha Savoie, Kevin P. Bateman, Brian Dean, Allena J. Ji, Jiang Wu, Amanda Wilson, Michael H. Buonarati, Jian Wang, Gustavo Mendes Lima Santos, Daniel S Spellman, Hendrik Neubert, Hui Zhang, Scott G. Summerfield, Eric Yang, Nilufer Tampal, Parya Nouri, Christopher J Beaver, Anna Edmison, Christine Fandozzi, Troy Voelker, Jenny Zhang, Fabio Garofolo, Michael McGuinness, Sam Haidar, Bill Mylott, Stephen Vinter, Arindam Dasgupta, Patrick Faustino, Daniela Fraier, Wenying Jian, Tahseen Mirza, Sune Sporring, Diaa Shakleya, Timothy V Olah, Eric Woolf, Stephen C. Alley, Nicola Hughes, Suman Dandamudi, Hongbin Yu, Phillip Sundman, Rebecca Elliott, Lina Luo, Jan Welink
Publikováno v:
Bioanalysis. 13:203-238
The 14th edition of the Workshop on Recent Issues in Bioanalysis (14th WRIB) was held virtually on June 15–29, 2020 with an attendance of over 1000 representatives from pharmaceutical/biopharmaceutical companies, biotechnology companies, contract r
Autor:
Mark Jairaj, Jianing Zeng, Kevin P. Bateman, Jens Sydor, Jim Glick, John F. Kellie, Surinder Kaur
Publikováno v:
Bioanalysis. 12:257-270
Increasingly diverse large molecule modalities have driven the need for complex bioanalysis and biotransformation assessment involving both traditional ligand-binding assays (LBA) and more recent hybrid immunoaffinity LC–MS platforms. Given the sci
Autor:
LaKenya Williams, Manuela Braun, Douglas Donaldson, Mark G. Qian, Carol Gleason, Tobias Haslberger, Boris Gorovits, Ling He, Jorge Quiroz, Enaksha R Wickremsinhe, David Christopher, Catherine L Brockus, Jens Sydor, Renuka Pillutla
Publikováno v:
Bioanalysis. 12(12)
Historically, ligand-binding assays for pharmacokinetic samples employed duplicate rather than singlet-based analysis. Herein, the Translational and absorption, distribution, metabolism and excretion (ADME) Sciences Leadership Group of the Internatio
Autor:
Charles S Hottenstein, Seongeun Julia Cho, Dina Goykhman, Daniela Verthelyi, Jens Sydor, Natasha Savoie, Steven P. Piccoli, Stephanie Fraser, Alex Bulychev, Elana Cherry, Yan Zhang, Anna Edmison, Ingo Röhl, Daniela Fraier, Lieve Dillen, Fabio Garofolo, Yoshiro Saito, Michael H. Buonarati, Adrien Musuku, Timothy Sangster, Barry R Jones, Eric Yang, Ragu Ramanathan, Tate Owen, Nico C van de Merbel, Anton I. Rosenbaum, Christopher Stebbins, Allena J. Ji, Daniel A. Norris, Akiko Ishii-Watabe, Rachel Green, Sean Kassim, Emma Whale, Amanda Wilson, Lina Luo, Neil Henderson, Christopher A. James, Sam Haidar, Alexander Behling, Nicola Hughes, Yuanxin Xu, Scott G. Summerfield, Isabelle Cludts, Stephen Vinter, Tom Verhaeghe, Gustavo Mendes Lima Santos, Robert Dodge, Eric Woolf, Mark Ma, Jan Welink, Kirk Brown, Uma Kavita, Hyun Gyung Jang
Publikováno v:
Bioanalysis. 10:1781-1801
The 2018 12th Workshop on Recent Issues in Bioanalysis (12th WRIB) took place in Philadelphia, PA, USA on April 9–13, 2018 with an attendance of over 900 representatives from pharmaceutical/biopharmaceutical companies, biotechnology companies, cont
Metabolism and Disposition of Pan-Genotypic Inhibitor of Hepatitis C Virus NS5A Ombitasvir in Humans
Autor:
Volker Fischer, Olga Kavetskaia, Jens Sydor, Bruce W. Surber, Anthony J. Lee, Sonia M. de Morais, Rajeev M. Menon, Junli Ma, Jianwei Shen, Michael Serby, Prajakta S. Badri
Publikováno v:
Drug Metabolism and Disposition. 44:1148-1157
Ombitasvir (also known as ABT-267) is a potent inhibitor of hepatitis C virus (HCV) nonstructural protein 5A (NS5A), which has been developed in combination with paritaprevir/ritonavir and dasabuvir in a three direct-acting antiviral oral regimens fo
Autor:
Anil Vasudevan, Ana Lucia Relo, Irini Akritopoulou-Zanze, Hongyu Zhao, Mario Mezler, Carolin Hoft, Willi Amberg, Frauke Pohlki, Ying Wang, Yi-Yin Ku, Justin D. Dietrich, Michael Ochse, Yanbin Lao, Huan-Qiu Li, Steven M. Hannick, Jason T. Brewer, Berthold Behl, Jens Sydor, Udo Lange, Wilfried Hornberger
Publikováno v:
Journal of medicinal chemistry. 61(17)
The glycine transporter 1 (GlyT1) has emerged as a key novel target for the treatment of schizophrenia. Herein, we report the synthesis and biological evaluation of aminotetralines and aminochromanes as novel classes of competitive GlyT1 inhibitors.
Autor:
Udo Lange, Yanbin Lao, Wilfried Hornberger, Frauke Pohlki, Jens Sydor, Mario Mezler, Jason T. Brewer, Stevan W. Djuric, Berthold Behl, Irini Akritopoulou-Zanze, Justin D. Dietrich, Ana Lucia Relo, Hongyu Zhao, Carolin Hoft, Huan-Qiu Li, Ying Wang, Anil Vasudevan, Willi Amberg
Publikováno v:
Journal of medicinal chemistry. 61(17)
The development of glycine transporter 1 (GlyT1) inhibitors may offer putative treatments for schizophrenia and other disorders associated with hypofunction of the glutaminergic N-methyl-d-aspartate (NMDA) receptor. Herein, we describe the synthesis
Autor:
Masanori Tachikawa, Yasuo Uchida, Dominik Gartzke, Gert Fricker, Tetsuya Terasaki, Yutaro Hoshi, Jens Sydor, Loic Laplanche, Jürgen Delzer
Publikováno v:
Pharmaceutical Research. 32:2060-2071
To investigate whether it is possible to specifically suppress the expression and function of endogenous canine P-glycoprotein (cPgp) in Madin-Darby canine kidney type II cells (MDCKII) transfected with hPGP and breast cancer resistance protein (hBCR
Autor:
Laura Coppola, Emma Whale, Chad Briscoe, Eric Yang, Jeff Duggan, Ragu Ramanathan, Stephen Vinter, Rafiq Islam, Mark E. Arnold, Rand Jenkins, Akiko Ishii-Watabe, Brad Ackermann, Gustavo Mendes Lima Santos, Nicola Hughes, Daniela Fraier, Adrien Musuku, Hanlan Liu, Scott G. Summerfield, Lucinda Hittle, Sean Kassim, Rachel Green, Sam Haidar, Sekhar Surapaneni, Yoshiro Saito, Mark Bustard, Nilufer Tampal, Olga Kavetska, Jens Sydor, Stephen C. Alley, John T Mehl, Tom Verhaeghe, Brian Rago, Michael H. Buonarati, Olivier Le Blaye, Wenkui Li, Isabella Berger, Mark Cancilla, Eric Woolf, Matthew Szapacs, Seongeun Julia Cho, Natasha Savoie, John Kadavil, Fabio Garofolo, Barry R Jones, Anita Lee, Jan Welink
Publikováno v:
Bioanalysis. 9(22)
The 2017 11th Workshop on Recent Issues in Bioanalysis (11th WRIB) took place in Los Angeles/Universal City, California from 3 April 2017 to 7 April 2017 with participation of close to 750 professionals from pharmaceutical/biopharmaceutical companies
Autor:
Grace E. Kim, Jens Sydor
Publikováno v:
Bioanalysis. 9(16)